<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><description>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 30 Jan 2021 11:37:14 +0800</pubDate><image><url>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</url><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>强生单剂新冠疫苗达到3期临床主要终点，下周递交EUA申请</title><link>https://mp.weixin.qq.com/s/CYqc3nt1yBeEPDQb-Ww4uQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5um4H79K9xw4B0kibbL8oFRibppLnBNAbhpd8xCWlDc1VFNxNmHiazMAJtYg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>罕见病专栏 | 一周罕闻药事（1.23-1.29）</title><link>https://mp.weixin.qq.com/s/-q8Sx5d-JFXlLFh28V0ynQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNDMeJZiaFaqUv0lLceQMa9ty1gibZQWibPicficre59nB0wZjJib5kdHo18yicQHGq9Se99gJ6KCvafYW2A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>罕闻药事，为您汇总罕见病研发领域最新资讯]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>89.3％防护效力，Novavax公布新冠疫苗英国3期临床试验结果</title><link>https://mp.weixin.qq.com/s/E0Xt6DVp5Z7whzGheVkERw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5umJ37IPwiblqkULLWXKYjxDticujxPAcUbXONoXtIK3j5KCianIF7XciaR8Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>南非出现的新冠病毒突变株对保护能力产生影响]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>速递 | 治疗非小细胞肺癌，TROP2靶向ADC临床结果积极</title><link>https://mp.weixin.qq.com/s/CkrVYmEZThBLDYziPXnc0Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5umT5bn6H9L0eG6XEo0wB10VQcODVz2NmWv7YJhRw8Dnz2Lo0icW0lxR9w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>“具有变革晚期肺癌靶向治疗的潜力”]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>疾病控制率达74%，杨森EGFR/MET双特异性抗体治疗特定非小细胞肺癌结果积极</title><link>https://mp.weixin.qq.com/s/kAUddl5XTywF7E6IDVKiLQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNibwc8hIwdVWkQzibic29M5um9OnuczxGU4hLjBhuog9DHQabmObNBTlGEsicponOicG9WwhStzGPOZxg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>已经向FDA递交新药申请]]></content:encoded><pubDate>Sat, 30 Jan 2021 07:53:46 +0800</pubDate></item><item><title>《自然》子刊综述：乳腺癌的治疗现状与未来</title><link>https://mp.weixin.qq.com/s/xo8RXqTAzFnt-wYB27RtDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLNrBr9cO9e9O1Ikvj7jYASXDT8iaJeTNKmJ8Nu7OiatOiagGDyLxeRxNoQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2020年全球新发乳腺癌达到226万例，首次超过肺癌（221万例）成为全球第一大癌症。]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item><item><title>如何从“偶尔治愈”迈向“经常治愈”？ | 药明康德全球论坛实录</title><link>https://mp.weixin.qq.com/s/xWSKAuaszgLtz_wTea0u3A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLPtoYtoIMmTFxelOdXudayN3oeibJaKyFZRcYIuGsmCdSicX6fR8miawAQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>来自著名投资人Robert Nelsen先生的见解]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item><item><title>速递 | 治疗非小细胞肺癌，安进KRAS抑制剂达到80.6%疾病控制率</title><link>https://mp.weixin.qq.com/s/nH2B-kPNIVDGb6SYWnJOCg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLUD3kPPzpbFyLqAJ6iaEP7o16ZKlKyX9cpAezMWJdYLI3EYgkicPyjwBg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>首次公布随访时间超过一年的关键性2期临床数据]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item><item><title>速递 | 治疗特定非小细胞肺癌，武田创新疗法达到78%疾病控制率</title><link>https://mp.weixin.qq.com/s/1ZXy-ETwoAFvcoFq5sdl4w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLfpd3BPItMtwRqpJEZ1QotDuYhnAvCRebZgDlzgyVEGicodeDOEibf5tg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>获美国FDA突破性疗法认定和中国药监局突破性治疗品种资格]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item><item><title>新冠变异毒株导致免疫保护力降低，何大一教授团队再添证据</title><link>https://mp.weixin.qq.com/s/ukAChhTlNLLKLqWtI2eT9Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLUoViaod3HaPDZyluXWueyA7DgMvkHEGGZWYY5ibOWhpUFYDXx66AqOLg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>多组数据显示病毒突变增强了逃逸能力]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item><item><title>NEJM：核酸阳性就有传染性吗？患者样本持续追踪揭示新冠病毒失活时间</title><link>https://mp.weixin.qq.com/s/xwqvcOyI3M-JVICnRy1v6Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqL5NNibAtbAI8eDWjbNRj4svtD3KfyrKsUCVxRkvicU4ckzq44N4Wc99ug/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>脱落病毒失活的时间远短于核酸转阴所需时间]]></content:encoded><pubDate>Fri, 29 Jan 2021 08:09:49 +0800</pubDate></item><item><title>专访洪志博士：乙肝创新疗法脱颖而出，对患者具有怎样的意义？</title><link>https://mp.weixin.qq.com/s/MVcXr_sw16sXANRmIUKhFw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8sB7qr4m4ljTxiaByW2YqLg9CsUJYv9EOqmKpnibLbGtgrjXKvhfKViak9xQ9ibic3NpQPianL6Braiadw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:19:27 +0800</pubDate></item><item><title>对话ASCO主席：2021“复苏之年”，肿瘤学将走向何方？ | 药明康德全球论坛实录</title><link>https://mp.weixin.qq.com/s/Gvqfk9fW3tks0WhZIKwCpQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gM8D7a7jiaGGeNWBicQ302fJwLiab5Mic5VBU96s3XOt7T7xOM3zKWibRApyQBYSficEhqibHG8mJN22ogkg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>进步的本质在于可以现实地期望得到什么]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:19:27 +0800</pubDate></item><item><title>速递 | 强强联手！礼来、GSK、Vir合作开发中和抗体组合疗法</title><link>https://mp.weixin.qq.com/s/ouBYgFrdnrX8pgAIkP7uYQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gMxzTict52CqfIYFJjaPoYf5KW1HV3FWu4aVz5lINf8gqeKUw7VD1n8ibLQ82hzoSIZOpuPk2EAla5w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>应对新冠病毒可能出现的变异]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:19:27 +0800</pubDate></item><item><title>《自然》子刊：通过分析149项AAV基因疗法临床试验，发现了这些趋势......</title><link>https://mp.weixin.qq.com/s/G54pKphvxac_yuiJH4VYyg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mfqJoCeoVIsvP8qsSWyn2fjOy4WM7ib027vUYibRCarx2SmehFM2HFurpdDkultQFLqUTD3qTD2od1qiaMGdyPjcA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>AAV基因治疗，有哪些新趋势？]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:19:27 +0800</pubDate></item><item><title>“任何糖尿病患者都要筛查肝病！”患病率惊人却被忽视，多学科声明呼吁行动</title><link>https://mp.weixin.qq.com/s/mF___hGpxViJ_KXj7bPyUQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/EIicaxb3hLFXOfxZAWSx5vpBLfGkbGNbegDkvtVvhNVRESibQJkeLcRWpVgngH6z4wGdw59KZQzvZl0lUOTzibZ0w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>需要重视筛查和针对性治疗]]></content:encoded><pubDate>Thu, 28 Jan 2021 08:19:27 +0800</pubDate></item><item><title>达到两个100%！中和抗体治疗/预防新冠疾病均获突破</title><link>https://mp.weixin.qq.com/s/rCXfw6gCXqCcNMLF4E33aQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOx2vczN5vjrFZGOhtB1NLQIa1oXYF6kE7wbkmQd1P33eolmg6iczyI7IJJAUrico7nThqVRF8z9d5A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Wed, 27 Jan 2021 08:00:39 +0800</pubDate></item><item><title>速递 | 治疗乙肝，中和抗体取得“意外”优异结果</title><link>https://mp.weixin.qq.com/s/Gj0bamJThQcgDmGuvyVBgg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOx2vczN5vjrFZGOhtB1NLQvdibreFL5XDWj6OZ5JsxN85LCqEuetltIubgEfB48dDCWFwYicrAyJqw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Wed, 27 Jan 2021 08:00:39 +0800</pubDate></item><item><title>第21届世界肺癌大会：基石药业、贝达药业、恒瑞医药精彩报告抢先看！</title><link>https://mp.weixin.qq.com/s/5e6XQ_VWYmMhHBy2QNTbHw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOx2vczN5vjrFZGOhtB1NLQ5JEj9ibOS4VBPwtHJbQPRenXOodT9alANr11Fhgib4RFSUDI9yxKoZ1Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>针对RET融合阳性NSCLC、HER2突变NSCLC等]]></content:encoded><pubDate>Wed, 27 Jan 2021 08:00:39 +0800</pubDate></item><item><title>速递 | Agios创新别构激活剂达到3期临床终点，第二季度有望递交监管申请</title><link>https://mp.weixin.qq.com/s/4WTOD_-HPkvWxpOYImNTjw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOx2vczN5vjrFZGOhtB1NLQnCrdibonCbpYtFX3bYUgpGtceKO0XEBfN1V7lcWvviarUbycE1I6InUQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有望成为首款改变疾病进程的获批疗法]]></content:encoded><pubDate>Wed, 27 Jan 2021 08:00:39 +0800</pubDate></item></channel></rss>